CAS: 873310-28-2

M-Methyl atomoxetine hydrochloride is a chemical compound, classified as a pharmaceutical intermediate or research chemical. It is synthesized from atomoxetine, a selective norepinephrine reuptake inhibitor (NRI). The compound functions by inhibiting the transporter responsible for the reabsorption of norepinephrine, thus increasing its availability in the synaptic cleft. The primary application of M-Methyl atomoxetine hydrochloride is in scientific research, particularly in the study of neurological and psychiatric disorders, such as ADHD and depression. Researchers utilize this compound to understand the mechanisms of norepinephrine modulation and its effects on cognitive and behavioral processes. Its unique mechanism provides insights into the therapeutic potential and neurochemical pathways involved in norepinephrine regulation.

Impurity Atomoxetine EP Impurity D Applications m-Methyl Atomoxetine Hydrochloride (Atomoxetine EP Impurity D) is an impurity of Atomoxetine (A791400), a norepinephrine reuptake inhibitor. References Farid, N.A., et al.: J. Clin. Pharmacol., 25, 296 (1985), Gehlert, D.R., et al.: J. Neurochem., 64, 2792 (1995), Hwamg. et al.: Neurosci. Lett., 265, 151 (1999), Ring, B.J., et al.: Drug Metab. Dispos., 30, 319 (2002),